As an additional level of complexity, the increased amounts of soluble NKG2D ligands, MICs and ULBPs, in blood from moderate/severe COVID19, suggest that blocking LAG3, TIM3 and/or PD1 still might not be sufficient to generate optimal antiviral responses during COVID19. The gene discussed is LAG3; the disease is COVID-19.